Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
Clinical trial NCT00956293 · TERMINATED
Trial details
- NCT number
- NCT00956293
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.